Following the recent clearance of its FreeStyle Lite® blood glucose test strips, Abbott announced that it has also received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new FreeStyle blood glucose test strips. The new FreeStyle test strips minimize interference during blood glucose testing and are designed to offer a better testing experience...
Following the recent clearance of its FreeStyle Lite® blood glucose test strips, Abbott announced that it has also received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new FreeStyle blood glucose test strips. The new FreeStyle test strips minimize interference during blood glucose testing and are designed to offer a better testing experience...
I was forced to innovate and try new things that I never would have considered eating -- boiled taro root, cassava, kale, collard greens, amaranth, and virtually any sort of meat, including once, kangaroo...
Bristol-Myers announced that findings from a 24-week Phase 3 clinical study, published online in the latest issue of Diabetes Care, demonstrated that the investigational drug dapagliflozin, administered as a monotherapy, achieved statistically significant mean reductions at 5 mg and 10 mg doses once daily in the primary endpoint of HbA1c levels...
Now out from HarperPaperbacks, 101 Places Not To See Before You Die -- by ASweetLife contributor Catherine Price -- is a guide to some of the least appealing destinations and experiences in the world.
Eli Lilly and Company announced they're teaming up with Walmart to provide an affordable insulin option for people with diabetes.
Beginning in mid-September, Lilly's Humulin(R) brand of insulin will be available in Walmart pharmacies...
Novo Nordisk today announced the decision to re-initiate the global phase 3 development program of liraglutide for the treatment of obesity.
Following the US approval of Victoza for the treatment of type 2 diabetes, Novo Nordisk has been in dialogue with the FDA regarding the further progression of the development program investigating...